Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
2-chloro-N6-Cyclopentyladenosine is an adenosine A1 receptor antagonist.1 It selectively binds to adenosine A1 over adenosine A2 receptors (Kis = 0.4 and 3,900 nM, respectively) and inhibits forskolin-induced adenylate cyclase activity in rat fat cell membranes, which endogenously express adenosine A1 receptors (IC50 = 33 nM). 2-chloro-N6-Cyclopentyladenosine (0.25 and 0.5 mg/kg) increases the electroconvulsive threshold in a mouse model of seizures induced by maximal electroshock (MES).2 It reduces infarct size in a rabbit model of coronary artery occlusion-induced myocardial infarction when administered at a dose of 0.125 mg/kg.3
WARNING This product is not for human or veterinary use.
1. 2-
2. 2-
3. Pretreatment with the adenosine A1 selective agonist, 2-